STOCK TITAN

[SCHEDULE 13G] Profusa, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Schedule 13G filed 24-Jul-2025 shows a group comprised of Ascent Partners Fund LLC, Dominion Capital and related entities plus individuals Mikhail Gurevich, Gennadiy Gurevich and Alon Brenner collectively own 3,359,068 Profusa (PFSA) common shares, equal to 9.99 % of shares outstanding as of 11-Jul-2025. The stake includes up to 820,475 shares issuable on conversion of a convertible promissory note; the note carries a 9.99 % ownership “blocker,” limiting additional conversions. All voting and dispositive power is reported as shared; no party claims sole control.

The percentage is calculated against the company’s 32,788,877 shares outstanding disclosed in a 18-Jul-2025 8-K. Because the filing is on Form 13G rather than 13D, the group certifies the position is passive and not intended to influence control. Exhibit 1 contains a joint filing agreement. The presence of an institutional investor group near the 10 % threshold signals outside confidence but also points to potential future dilution should the remaining note principal be converted once the blocker is lifted or expires.

Positive

  • Institutional validation: A sophisticated investor group elected to hold nearly 10 % of PFSA, indicating confidence in the company’s prospects.
  • Passive filing: Use of Schedule 13G suggests no immediate activist pressure on management.

Negative

  • Dilution overhang: Remaining convertible note principal could add shares beyond the 9.99 % blocker, expanding the float.
  • Disclosure inconsistency: Item 4 lists 99.99 % ownership, conflicting with the 9.99 % figure elsewhere and requiring clarification.

Insights

TL;DR: 9.99 % passive stake signals confidence but flags dilution risk from convertible note.

The Ascent-Dominion group’s capped ownership introduces a sophisticated investor that may support Profusa’s capital needs. A passive 13G reduces governance overhang versus a 13D activist filing, yet the sizeable convertible note—already partly converted—could expand the float if the blocker is removed. Investors should watch for amendment filings that raise ownership or shift to a 13D, which would imply a strategic agenda.

TL;DR: Joint filers avoid control intent, keeping governance stable for now.

Because voting/dispositive power is shared and limited to under 10 %, the group sidesteps short-swing profit rules and additional filing burdens. Management retains control leverage, but any future ownership increase past the 10 % line would trigger heightened disclosure and potential board negotiation. The typo showing 99.99 % in Item 4 warrants clarification but is unlikely material.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of common stock, par value $0.0001 per share of the issuer (the "Common Stock") set forth on rows (6), (8) and (9) above includes the conversion, up to the Blocker (as defined in this footnote) amount, of a convertible promissory note (the "Convertible Note") directly and indirectly held by the reporting person, which Convertible Note is subject to a maximum 9.99% beneficial ownership limitation provision contained therein (the "Blocker"). In Row (11) the percentage is based on (i) 32,788,877 shares of Common Stock outstanding, as reported by the issuer in its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on July 18, 2025 (the "Form 8-K"), and (ii) 820,475 shares of Common Stock issuable upon partial conversion of the Convertible Note directly and indirectly held by the reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes the conversion, up to the Blocker amount, of the Convertible Note directly held by the reporting person, which Convertible Note is subject to the Blocker. In Row (11) the percentage is based on (i) 32,788,877 shares of Common Stock outstanding, as reported by the issuer in its Form 8-K, and (ii) 820,475 shares of Common Stock issuable upon partial conversion of the Convertible Note directly held by the reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes the conversion, up to the Blocker amount, of the Convertible Note directly and indirectly held by the reporting person, which Convertible Note is subject to the Blocker. In Row (11) the percentage is based on (i) 32,788,877 shares of Common Stock outstanding, as reported by the issuer in its Form 8-K, and (ii) 820,475 shares of Common Stock issuable upon partial conversion of the Convertible Note directly and indirectly held by the reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes the conversion, up to the Blocker amount, of the Convertible Note directly and indirectly held by the reporting person, which Convertible Note is subject to the Blocker. In Row (11) the percentage is based on (i) 32,788,877 shares of Common Stock outstanding, as reported by the issuer in its Form 8-K, and (ii) 820,475 shares of Common Stock issuable upon partial conversion of the Convertible Note directly and indirectly held by the reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes the conversion, up to the Blocker amount, of the Convertible Note directly and indirectly held by the reporting person, which Convertible Note is subject to the Blocker. In Row (11) the percentage is based on (i) 32,788,877 shares of Common Stock outstanding, as reported by the issuer in its Form 8-K, and (ii) 820,475 shares of Common Stock issuable upon partial conversion of the Convertible Note directly and indirectly held by the reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes the conversion, up to the Blocker amount, of the Convertible Note directly held by the reporting person, which Convertible Note is subject to the Blocker. In Row (11) the percentage is based on (i) 32,788,877 shares of Common Stock outstanding, as reported by the issuer in its Form 8-K, and (ii) 820,475 shares of Common Stock issuable upon partial conversion of the Convertible Note directly held by the reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes the conversion, up to the Blocker amount, of the Convertible Note directly and indirectly held by the reporting person, which Convertible Note is subject to the Blocker. In Row (11) the percentage is based on (i) 32,788,877 shares of Common Stock outstanding, as reported by the issuer in its Form 8-K, and (ii) 820,475 shares of Common Stock issuable upon partial conversion of the Convertible Note directly and indirectly held by the reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes the conversion, up to the Blocker amount, of the Convertible Note directly and indirectly held by the reporting person, which Convertible Note is subject to the Blocker. In Row (11), the percentage is based on (i) 32,788,877 shares of Common Stock outstanding, as reported by the issuer in its Form 8-K, and (ii) 820,475 shares of Common Stock issuable upon partial conversion of the Convertible Note directly held by the reporting person.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes the conversion, up to the Blocker amount, of the Convertible Note directly and indirectly held by the reporting person, which Convertible Note is subject to the Blocker. In Row (11), the percentage is based on (i) 32,788,877 shares of Common Stock outstanding, as reported by the issuer in its Form 8-K, and (ii) 820,475 shares of Common Stock issuable upon partial conversion of the Convertible Note directly held by the reporting person.


SCHEDULE 13G



Ascent Partners Fund LLC
Signature:/s/ Ascent Partners Fund LLC
Name/Title:Mikhail Gurevich, signatory for managing member of managing member
Date:07/24/2025
Ascent Partners LLC
Signature:/s/ Ascent Partners LLC
Name/Title:Mikhail Gurevich, signatory for managing member
Date:07/24/2025
Dominion Capital LLC
Signature:/s/ Dominion Capital LLC
Name/Title:Mikhail Gurevich, Managing Member of Dominion Capital Holdings LLC, Manager of Dominion Capital GP LLC, Manager of Dominion Capital LLC
Date:07/24/2025
Dominion Capital GP LLC
Signature:/s/ Dominion Capital GP LLC
Name/Title:Mikhail Gurevich, Managing Member of Dominion Capital Holdings LLC, Manager of Dominion Capital GP LLC
Date:07/24/2025
Dominion Capital Holdings LLC
Signature:/s/ Dominion Capital Holdings LLC
Name/Title:Mikhail Gurevich, Managing Member
Date:07/24/2025
Masada Group Holdings LLC
Signature:/s/ Masada Group Holdings LLC
Name/Title:Alon Brenner, Managing Member
Date:07/24/2025
Mikhail Gurevich
Signature:/s/ Mikhail Gurevich
Name/Title:Mikhail Gurevich
Date:07/24/2025
Gennadiy Gurevich
Signature:/s/ Gennadiy Gurevich
Name/Title:Gennadiy Gurevich
Date:07/24/2025
Alon Brenner
Signature:Alon Brenner
Name/Title:Alon Brenner
Date:07/24/2025
Exhibit Information

Exhibit 1 - Joint Filing Agreement

Profusa Inc

NASDAQ:PFSA

View PFSA Stock Overview

PFSA Rankings

PFSA Latest News

PFSA Latest SEC Filings

PFSA Stock Data

712.45k
1.21M
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
NEW YORK